Silver Book Fact

Eliminating out-of-pocket drug costs for combination pharmacotherapy for the 423,000 Americans with drug insurance who will experience their first myocardial infarction in 2006 would save 4,736 lives, and would save insurers more than $2.5 billion.

Choudhry, Niteesh, Jerry Avorn, Elliot M. Antman, Sebastian Schneeweiss, and William H. Shrank. Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An economic analysis. Health Affairs. 2007; 26(1): 186-194. https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.26.1.186?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed

Reference

Title
Should Patients Receive Secondary Prevention Medications For Free After A Myocardial Infarction? An economic analysis
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2007
Authors
Choudhry, Niteesh, Jerry Avorn, Elliot M. Antman, Sebastian Schneeweiss, and William H. Shrank
Volume & Issue
Volume 26, Issue 1
Pages
186-194
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Life expectancy and quality of life gains from AVR
    A study of 4,617 patients who underwent aortic valve replacement (AVR) over a period of 20 years found significant gains in life expectancy and quality of life — 43,166 net life-years…  
  • Compared to standard coverage, 3 years of full coverage for prevention medications will reduce mortality and reinfarction rates and will save $5,974 per patient.  
  • Without antihypertensive therapies, blood pressures (at age 40+) would have been between 10% and 13% higher in 1999-2000. Additionally, 86,000 excess premature deaths from cardiovascular disease would have occurred in…  
  • In 1995, an NIH-funded clinical trial established the first FDA-approved treatment for acute ischemic stroke treatment.The drug tPA, if given within 3 hours of stroke symptoms, reduces the risk of…  
  • During the 1970s and 1980s, the gains associated with the prevention and treatment of cardiovascular disease totaled $31 trillion.